Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 19, Issue 7, Pages 431-434Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/d41573-020-00110-3
Keywords
-
Ask authors/readers for more resources
Emerging evidence suggests that SARS-CoV-2 can drive a diverse array of immune processes, raising the risk that immunosuppressant agents that are in clinical trials might be effective for some patients but detrimental for others.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available